IGF2BP1 and seminoma: For instance, Wei et al. demonstrated that METTL3 cooperated with IGF2BP1 to increase the stability of transcription factor-activating enhancer-binding protein 2C (TFAP2C) mRNA, while the increase of TFAP2C expression level potentiated the resistance to cisplatin in seminoma (Wei et al., 2020).